CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lukaka@cato-chem.com
Timolol Maleate

马来酸噻吗洛尔 杂质对照品Timolol Maleate Impurities

EP32 个杂质条目32 impurity entries

本页汇总 马来酸噻吗洛尔 的 32 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 32 impurity reference standards of Timolol Maleate with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 马来酸噻吗洛尔(Timolol Maleate)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesComprehensive Analytical Method Development for Related Substance Determination in Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solutions: Multi-Method Approach and Regulatory Compliance
    Biomedical chromatography : BMC · 2026 · Kapavarapu R, Mantena SK  ·  PMID 42289391  ·  DOI
  2. 杂质研究Impurity studiesA novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form
    Journal of chromatographic science · 2012 · Sharma N et al.  ·  PMID 22562819  ·  DOI
  3. 杂质研究Impurity studiesA stability-indicating RP-HPLC method for the simultaneous quantification of brimonidine tartrate and timolol maleate in bulk drug substances and pharmaceutical dosage forms
    Scientific reports · 2026 · Mestareehi A  ·  PMID 41491002  ·  DOI
  4. 分析方法Analytical MethodsDevelopment and Validation of Facile RP-HPLC Method for Simultaneous Determination of Timolol Maleate, Moxifloxacin Hydrochloride, Diclofenac Sodium and Dexamethasone in Plasma, Aqueous Humor and Pharmaceutical Products
    Journal of chromatographic science · 2023 · Shahzad A et al.  ·  PMID 35870199  ·  DOI
  5. 分析方法Analytical MethodsRP-HPLC method development for the simultaneous determination of timolol maleate and human serum albumin in albumin nanoparticles
    Journal of pharmaceutical and biomedical analysis · 2015 · Boiero C et al.  ·  PMID 25890214  ·  DOI

马来酸噻吗洛尔 —— 原料药与杂质对照品Timolol Maleate — drug substance & impurities

共 32 个条目(含原料药本体)32 items incl. the drug substance
Timolol Maleate structure
EP原料药 APIAPI
马来酸噻吗洛尔Timolol Maleate
Timolol Maleate
CAS No.26921-17-5
Chemical FormulaC13H24N4O3S·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 1 (Timolol Maleate EP Impurity A Maleate Salt) structure
EPA
马来酸噻吗洛尔杂质1 (马来酸噻吗洛尔EP杂质A 马来酸盐)Timolol Maleate Impurity 1 (Timolol Maleate EP Impurity A Maleate Salt)
Timolol Maleate Impurity 1 (Timolol Maleate EP Impurity A Maleate Salt)
CAS No.26839-77-0
Chemical FormulaC13H24N4O3S·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 2(Timolol Maleate EP Impurity B) structure
EPB
马来酸噻吗洛尔杂质2(马来酸噻吗洛尔EP杂质B)Timolol Maleate Impurity 2(Timolol Maleate EP Impurity B)
Timolol Maleate Impurity 2(Timolol Maleate EP Impurity B)
CAS No.59697-06-2
Chemical FormulaC13H24N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 3 Monomer (Timolol Maleate EP Impurity C) structure
EPC
马来酸噻吗洛尔杂质3 单体 (马来酸噻吗洛尔EP杂质C)Timolol Maleate Impurity 3 Monomer (Timolol Maleate EP Impurity C)
Timolol Maleate Impurity 3 Monomer (Timolol Maleate EP Impurity C)
CAS No.610271-56-2
Chemical FormulaC19H31N7O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 3 (Timolol Maleate EP Impurity C  Maleate) structure
EPC
马来酸噻吗洛尔杂质3 (马来酸噻吗洛尔EP杂质C 马来酸盐)Timolol Maleate Impurity 3 (Timolol Maleate EP Impurity C Maleate)
Timolol Maleate Impurity 3 (Timolol Maleate EP Impurity C Maleate)
CAS No.610271-57-3
Chemical FormulaC19H31N7O4S2·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 4(Timolol Maleate EP Impurity D) structure
EPD
马来酸噻吗洛尔杂质4(马来酸噻吗洛尔EP杂质D)Timolol Maleate Impurity 4(Timolol Maleate EP Impurity D)
Timolol Maleate Impurity 4(Timolol Maleate EP Impurity D)
CAS No.30165-97-0
Chemical FormulaC6H9N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 5 Monomer (Timolol Maleate EP Impurity E) structure
EPE
马来酸噻吗洛尔杂质5 单体 (马来酸噻吗洛尔EP杂质E)Timolol Maleate Impurity 5 Monomer (Timolol Maleate EP Impurity E)
Timolol Maleate Impurity 5 Monomer (Timolol Maleate EP Impurity E)
CAS No.1026075-53-5
Chemical FormulaC17H26N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 6 (Timolol Maleate EP Impurity F) structure
EPF
马来酸噻吗洛尔杂质6 (马来酸噻吗洛尔EP杂质F)Timolol Maleate Impurity 6 (Timolol Maleate EP Impurity F)
Timolol Maleate Impurity 6 (Timolol Maleate EP Impurity F)
CAS No.30165-96-9
Chemical FormulaC6H8ClN3OS
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 7 (Timolol Maleate EP Impurity G) structure
EPG
马来酸噻吗洛尔杂质7 (马来酸噻吗洛尔EP杂质G)Timolol Maleate Impurity 7 (Timolol Maleate EP Impurity G)
Timolol Maleate Impurity 7 (Timolol Maleate EP Impurity G)
CAS No.75202-36-7
Chemical FormulaC6H9N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 9(Timolol Maleate EP Impurity I) structure
EPI
马来酸噻吗洛尔杂质9(马来酸噻吗洛尔EP杂质I)Timolol Maleate Impurity 9(Timolol Maleate EP Impurity I)
Timolol Maleate Impurity 9(Timolol Maleate EP Impurity I)
CAS No.2469037-77-0
Chemical FormulaC11H20N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol-d9 structure
—
噻吗洛尔-d9Timolol-d9
Timolol-d9
CAS No.1286769-65-0
Chemical FormulaC13H15D9N4O3S
Purity>95%询价On request
Timolol Impurity 8 structure
8
噻吗洛尔杂质8Timolol Impurity 8
Timolol Impurity 8
CAS No.369377-82-2
Chemical FormulaC15H22N6O5S2
Purity>95%现货In stock
10mg25mg50mg100mg
Timolol Maleate Impurity 13 structure
13
马来酸噻吗洛尔杂质13Timolol Maleate Impurity 13
Timolol Maleate Impurity 13
CAS No.542-28-9
Chemical FormulaC5H8O2
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 14 structure
14
马来酸噻吗洛尔杂质14Timolol Maleate Impurity 14
Timolol Maleate Impurity 14
CAS No.19115-49-2
Chemical FormulaC6H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 15 structure
15
马来酸噻吗洛尔杂质15Timolol Maleate Impurity 15
Timolol Maleate Impurity 15
CAS No.57073-55-9
Chemical FormulaC13H24N4O3S·C4H4O4
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 16 structure
16
马来酸噻吗洛尔杂质16Timolol Maleate Impurity 16
Timolol Maleate Impurity 16
CAS No.158636-96-5
Chemical FormulaC13H24N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 17 structure
17
马来酸噻吗洛尔杂质17Timolol Maleate Impurity 17
Timolol Maleate Impurity 17
CAS No.1227468-61-2
Chemical FormulaC13H24N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 21 structure
21
马来酸噻吗洛尔杂质21Timolol Maleate Impurity 21
Timolol Maleate Impurity 21
CAS No.935528-00-0
Chemical FormulaC9H14ClN3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 23 structure
23
马来酸噻吗洛尔杂质23Timolol Maleate Impurity 23
Timolol Maleate Impurity 23
CAS No.214691-24-4
Chemical FormulaC6H9N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 24 structure
24
马来酸噻吗洛尔杂质24Timolol Maleate Impurity 24
Timolol Maleate Impurity 24
CAS No.741719-53-9
Chemical FormulaC9H13N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 25 structure
25
马来酸噻吗洛尔杂质25Timolol Maleate Impurity 25
Timolol Maleate Impurity 25
CAS No.295776-81-7
Chemical FormulaC9H15N3O4S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 27 structure
27
马来酸噻吗洛尔杂质27Timolol Maleate Impurity 27
Timolol Maleate Impurity 27
CAS No.58827-68-2
Chemical FormulaC9H13N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 29 structure
29
马来酸噻吗洛尔杂质29Timolol Maleate Impurity 29
Timolol Maleate Impurity 29
CAS No.131986-28-2
Chemical FormulaC7H4ClN3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 30 structure
30
马来酸噻吗洛尔杂质30Timolol Maleate Impurity 30
Timolol Maleate Impurity 30
CAS No.610271-58-4
Chemical FormulaC10H16N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 31 structure
31
马来酸噻吗洛尔杂质31Timolol Maleate Impurity 31
Timolol Maleate Impurity 31
CAS No.1422656-07-2
Chemical FormulaC7H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 32 structure
32
马来酸噻吗洛尔杂质32Timolol Maleate Impurity 32
Timolol Maleate Impurity 32
CAS No.3028600-06-5
Chemical FormulaC13H24N4O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 34 structure
34
马来酸噻吗洛尔杂质34Timolol Maleate Impurity 34
Timolol Maleate Impurity 34
CAS No.24308-29-0
Chemical FormulaC4H8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 35 structure
35
马来酸噻吗洛尔杂质35Timolol Maleate Impurity 35
Timolol Maleate Impurity 35
CAS No.19895-34-2
Chemical FormulaC7H10O2
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 40 structure
40
马来酸噻吗洛尔杂质40Timolol Maleate Impurity 40
Timolol Maleate Impurity 40
CAS No.1391068-18-0
Chemical FormulaC19H31N7O4S2
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 41 structure
41
马来酸噻吗洛尔杂质41Timolol Maleate Impurity 41
Timolol Maleate Impurity 41
CAS No.2608746-26-3
Chemical FormulaC13H24N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 43 structure
43
马来酸噻吗洛尔杂质43Timolol Maleate Impurity 43
Timolol Maleate Impurity 43
CAS No.69500-53-4
Chemical FormulaC9H13N3O3S
Purity>95%询价On request
10mg25mg50mg100mg
Timolol Maleate Impurity 15-d5 structure
15-D5
马来酸噻吗洛尔杂质15-d5Timolol Maleate Impurity 15-d5
Timolol Maleate Impurity 15-d5
CAS No.1217260-21-3
Chemical FormulaC13H19D5N4O3S·C4H4O4
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

马来酸噻吗洛尔 —— 研究文献与合成路线Timolol Maleate — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 马来酸噻吗洛尔 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Timolol Maleate. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Stability indicating HPTLC determination of timolol maleate as bulk drug and in pharmaceutical preparations
    Kulkarni SP, Amin PD · Journal of pharmaceutical and biomedical analysis · 2000 · 被引 29cited 29
  2. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form
    Sharma N, Rao SS, Reddy AM · Journal of chromatographic science · 2012 · 被引 12cited 12
  3. Comprehensive Analytical Method Development for Related Substance Determination in Dorzolamide Hydrochloride-Timolol Maleate Ophthalmic Solutions: Multi-Method Approach and Regulatory Compliance
    Kapavarapu R, Mantena SK · Biomedical chromatography : BMC · 2026
  4. Synthesis and Characterization of 3-S-impurities in Timolol Maleate
    Zhou D, Wang K, Zhang Y, et al. · Current organic synthesis · 2025
  5. Single quad mass analyzer coupled UPLC method for impurity profile of Brimonidine tartrate and Timolol maleate: Application in their binary mixture ophthalmic formulation
    Kondra S, Akula Thukaram B, Gowrisankar D, et al. · Annales pharmaceutiques francaises · 2021
  6. [Determination of enantiomeric impurity of timolol maleate in bulk substances and eye drops]
    Zhu QY, Yu LS, Zheng GG, et al. · Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2014

合成与制备工艺专利Synthesis & process patents

  1. Timolol maleate eye drops without bacteriostatic agent and preparation method thereof
    YAO JUN · 公开号 CN101474146CN101474146 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

马来酸噻吗洛尔 杂质谱研究要点Timolol Maleate — impurity profiling notes

下面这些是拿到 马来酸噻吗洛尔 的 32 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 32 impurity entries for Timolol Maleate, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances